BOND-003 Study

Clinicaltrials.gov ID:
NCT04452591

CG Oncology Study ID:
Cretostimogene grenadenorepvec (CG0070)

Condition:
Non-Muscle Invasive Bladder Cancer

Contact:
Recruitment@cgoncology.com

 

BOND-003 Study Patient Eligibility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided.

Download your Doctor Discussion Guide to help guide conversations with your health care professional: